ABI-007 in Taxol Resistant Patients With Metastatic Breast Cancer

Clinical trial NCT00046514 · COMPLETED

Trial details

NCT number: NCT00046514
Sponsor: Celgene Corporation
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Neoplasms Metastases, Neoplasm

Start date: 2001-06-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.